The acquisition adds the Imaras Beauty brand and a seasoned executive but lacks disclosed financials. Monitor the upcoming 71-day amendment for Adli's revenue, profitability, and pro forma impact. The consulting agreement ties Hefter's compensation to product sales to CVS and volume/profit milestones, providing potential upside catalysts.
Price Chart
Executive Summary
Healthy Extracts Inc. completed the acquisition of Adli Gummies Inc. (Imaras Beauty) on May 15, 2026, through its subsidiary HE Canada. Consideration included $794,000 in secured promissory notes and 3,000,000 shares of common stock (net ~17.76% dilution after CEO share cancellation). Aaron Hefter, Adli's CEO, was appointed as Chief Brand Officer. No financial statements are provided yet.
Key Financial Metrics
Key Facts
- Acquired 100% of Adli Gummies Inc. (Imaras Beauty) for $629,000 secured note to shareholders, $165,000 secured note to Aaron Hefter (repayment of shareholder loan), and 3,000,000 shares of common stock (2,159,520 HE Canada Class B shares exchangeable for HYEX common + 840,480 HYEX common shares)
- CEO Donald Swanson cancelled 3,000,000 shares concurrently, reducing net dilution to ~17.76% of post-cancellation outstanding
- Aaron Hefter appointed Chief Brand Officer under a 3-year consulting agreement with $10,000/month base compensation plus bonus incentives
- Financial statements and pro forma information to be filed within 71 days (amendment to this 8-K)
- Outstanding shares pre-deal: 16,890,868 common; post-cancellation and issuance, Hefter's exchangeable shares represent potential further dilution
Financial Impact
Total cash consideration is $794,000 in secured promissory notes; stock component value not disclosed (no market price available). The notes are payable from net profits of Adli product sales.
Risk Factors
- Integration risk and potential for lower-than-expected Adli revenue
- Dilution of 17.76% overhangs the stock; further dilution possible if Hefter exchanges his HE Canada shares
- Debt servicing from net profits may pressure cash flow if sales are weak
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 9 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001096906-26-000819 |
| Document: hyex_ex10z4.htm | 0001096906-26-000819 |
| Document: hyex_ex10z3.htm | 0001096906-26-000819 |
| Document: hyex-20260515_8k.htm | 0001096906-26-000819 |
| Document: hyex_ex10z2.htm | 0001096906-26-000819 |
| Document: hyex_ex10z5.htm | 0001096906-26-000819 |
| Document: 0001096906-26-000819-index-headers.html | 0001096906-26-000819 |
| Document: 0001096906-26-000819-index.html | 0001096906-26-000819 |
| Document: 0001096906-26-000819.txt | 0001096906-26-000819 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 18, 2026 5w ago | 8-K | $1.17 | awaiting T+60 | — | $1.29 (+9.96%) |
Jul 13, 2026 15w ago | 8-K | $1.75 $1.05 | ▼ −40.00% | ▼ −43.63% | $1.29 (−26.29%) |
Jul 6, 2026 16w ago | 8-K | $1.22 $1.05 | ▲ +13.93% | ▲ +17.02% | $1.29 (−5.74%) |
May 18, 2026 23w ago | 8-K | $1.25 $1.50 | ▲ +19.66% | ▲ +14.80% | $1.29 (+2.90%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers